Hayati Yarkadas Xylem Inc. (XYL) insider trading activity

Hayati Yarkadas is SVP & President, WI of Xylem Inc.. Currently has a direct ownership of 19,616 shares of XYL, which is worth approximately $2.34 Million. The most recent transaction as insider was on Mar 05, 2025, when has been sold 2,314 shares (Common Stock) at a price of $129.67 per share, resulting in proceeds of $300,056. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 19.6K

109.73% 3M change

109.73% 12M change

Total Value Held $2.34 Million

Hayati Yarkadas Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Mar 05 2025	BUY Grant, award, or other acquisition	$300,056 $129.67 p/Share	2,314 Added 10.55%	19,616 Common Stock
Mar 01 2025	SELL Payment of exercise price or tax liability	$82,410 $129.78 p/Share	635 Reduced 3.54%	17,302 Common Stock
Mar 01 2025	BUY Grant, award, or other acquisition	$1,112,993 $129.78 p/Share	8,576 Added 32.35%	17,937 Common Stock
Mar 05 2024	SELL Open market or private sale	$579,878 $127.53 p/Share	4,547 Reduced 32.71%	9,353 Common Stock
Mar 01 2024	SELL Open market or private sale	$3,112,377 $127.15 p/Share	24,478 Reduced 63.78%	13,900 Common Stock
Mar 01 2024	SELL Payment of exercise price or tax liability	$54,758 $127.94 p/Share	428 Reduced 2.23%	18,770 Common Stock
Mar 01 2024	BUY Grant, award, or other acquisition	$906,326 $127.94 p/Share	7,084 Added 26.95%	19,198 Common Stock
Mar 01 2024	BUY Exercise of conversion of derivative security	$1,895,897 $96.69 p/Share	19,608 Added 51.09%	18,775 Common Stock
May 07 2023	SELL Payment of exercise price or tax liability	$7,736 $108.97 p/Share	71 Reduced 0.58%	12,075 Common Stock
Mar 02 2023	SELL Open market or private sale	$1,601,055 $100.43 p/Share	15,942 Reduced 56.76%	12,146 Common Stock
Mar 02 2023	BUY Exercise of conversion of derivative security	$835,213 $75.17 p/Share	11,111 Added 28.35%	28,088 Common Stock
Mar 01 2023	SELL Payment of exercise price or tax liability	$10,311 $101.09 p/Share	102 Reduced 0.79%	12,773 Common Stock
Mar 01 2023	BUY Grant, award, or other acquisition	-	4,204 Added 19.85%	16,977 Common Stock
Feb 27 2023	SELL Payment of exercise price or tax liability	$37,943 $102.55 p/Share	370 Reduced 2.79%	12,875 Common Stock
Feb 27 2023	BUY Grant, award, or other acquisition	-	5,772 Added 30.35%	13,245 Common Stock
Feb 15 2023	SELL Open market or private sale	$222,756 $106.94 p/Share	2,083 Reduced 21.8%	7,473 Common Stock
Jun 27 2022	SELL Open market or private sale	$472,194 $80.06 p/Share	5,898 Reduced 38.16%	9,556 Common Stock
Jun 27 2022	BUY Exercise of conversion of derivative security	$374,818 $63.55 p/Share	5,898 Added 27.62%	15,454 Common Stock
Jun 21 2022	SELL Open market or private sale	$154,443 $74.18 p/Share	2,082 Reduced 17.89%	9,556 Common Stock
May 09 2022	SELL Open market or private sale	$6,478 $86.37 p/Share	75 Reduced 0.64%	11,638 Common Stock
Mar 02 2022	SELL Open market or private sale	$3,778 $87.87 p/Share	43 Reduced 0.52%	8,255 Common Stock
Mar 01 2022	SELL Open market or private sale	$6,149 $86.61 p/Share	71 Reduced 0.85%	8,298 Common Stock
Mar 01 2022	BUY Grant, award, or other acquisition	-	3,458 Added 22.79%	11,713 Common Stock
May 12 2021	SELL Open market or private sale	$71,548 $117.1 p/Share	611 Reduced 6.8%	8,369 Common Stock
May 07 2021	SELL Open market or private sale	$9,130 $120.13 p/Share	76 Reduced 0.84%	8,980 Common Stock

Hayati Yarkadas

SVP & President, WI

Washington, DC

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells XYL shares.

Notify only if

Value

Insider Trading

Get notified when an Xylem Inc. insider buys or sells XYL shares.

Notify only if

Operation

Value

Type

News

Receive news related to Xylem Inc.

Track Activities on XYL

Account